Following the administration of paracetamol (1g 4 times per day) or placebo to 10 healthy female volunteers for 2 days, the pharmacological effects of intravenous frusemide (20 mg) were observed after a final dose of either paracetamol or placebo. Paracetamol pre-treatment had no effect on frusemide-induced diuresis or natriuresis. There was a significant reduction in the basal output of prostaglandin E2 (PGE2) with paracetamol pre-treatment (18.4 ± 15.4 vs 7.6 ± 5.0 ng h-1, P < 0.05; 95% confidence interval of the difference 0.2 to 21.8). Frusemide induced a transient increase in the urinary excretion rate of PGE2 and although this effect was reduced by paracetamol (46.6 ± 50.9 vs 23.2 ± 13.8) the differences in the change of excretion rate from baseline were not statistically significant (95% confidence interval of the difference -17.8 to 15.7). The basal level of 6-keto prostaglandin Fla (PGFia) was less with paracetamol pre-treatment (61.7 ± 41.1 vs 38.7 ± 26.1 ng h-1, NS; 95% confidence interval of the difference -16.6 to 62.6) and the cumulative urinary output of PGFia in the 6 h after frusemide administration was significantly reduced ( 305.9 ± 179.4 vs 181.8 ± 100.2 ng h-1, P < 0.05; 95% confidence interval of the difference 32.2 to 216). The frusemide-induced rise in plasma renin activity was significantly less with paracetamol than placebo at 60 min (4.3 ± 2.9 vs 2.7 ± 1.9 ng ml-' h-', P < 0.01; 95% confidence interval of the difference 0.4 to 2.7).
Introduction Methods
Frusemide produces a marked increase in the excretion of renal prostaglandins which may mediate some of its pharmacological actions [1, 2] . Although the non-steroidal anti-inflammatory drugs which inhibit prostaglandin synthesis decrease the transient rise in plasma renin activity induced by frusemide [3] [4] [5] their effects on its natriuretic response are more controversial [6] . Some investigators have reported a reduced response [3] [4] [5] but others have not [7] [8] [9] . Paracetamol has been considered to be only a weak inhibitor of prostaglandin synthesis [10] but it caused a reduction in urinary PGE2 and sodium excretion in healthy female volunteers [11] . The present study investigates the effects of paracetamol on frusemideinduced diuresis, natriuresis, renal prostaglandin excretion and rise in plasma renin activity. The volunteers were instructed by the hospital dietician how to restrict their intake of sodium to 75 mmol per day for the 2 days before and during the study. They were asked to avoid sexual activity before the third study day on each occasion.
On the third study days an intravenous cannula was placed in a forearm vein and the fasting volunters took 200 ml of water at 08.00 h. They remained recumbent for 30 min and venous blood was sampled for basal plasma renin activity (PRA activity). At 08.30 h the bladder was emptied and the final dose of either placebo or paracetamol 1 g was taken with 200 ml water. The subjects remained recumbent and 1 h later blood was again sampled for PRA activity and a urine sample collected.
Frusemide 20 mg (Hoechst UK, Ltd) was then administered intravenously and blood was sampled at 15, 30 and 60 min for measurement of PRA activity. Urine was collected at 0.5, 1, 2, 4, 6 and 24 h. Fluid was replaced according to the volume of urine passed throughout the day. A light breakfast was served after the administration of frusemide and lunch was taken 3 h later.
Results

Frusemide induced diuresis and natriuresis
Intravenous frusemide caused a marked diuresis in the 30 min following its administration which was not altered by paracetamol pre-treatment (23.9 ± 2.5 vs 23.0 ± 5.8 ml min-, 95% confidence interval of the difference -2.6 to 4.4). Similarly, the corresponding frusemide-induced natriuresis was Analytical methods Plasma renin activity was measured by radioimmunoassay of angiotensin I generated under standard conditions [12] . Urinary sodium was measured by an ion selective electrode. Urinary PGE2 and 6-keto PGFia were measured by radioimmunoassay (Du Pont, UK, Ltd) and the method of Dray et al. [13] , respectively. The inter-and intra-assay coefficients of variation were 7% and 14% for PGE2 and 7% and 19% for 6-keto PGF1Q. (Figure la) . Similarly, the mean basal excretion rate of 6-keto PGF1Q was lower with paracetamol than with placebo pre-treatment (38.7 ± 26.1 vs 61.7 ± 41.1 ng h-1) but the differences were not significant (95% confidence interval of the difference -62.2 to 16.6, Figure lb) . In the 30 min following the administration of frusemide there was a transient increase in the urinary excretion rate of 6-keto PGF1Q which was less with paracetamol pre-treatment (61.7 ± 41.1 to 91.2 ± 58.9 vs 38.7 ± 26.1 to 65.7 ± 31.9 ng h-1). However, again the differences in the change of excretion rate from baseline were not statistically significant (95% confidence interval of the difference -33.4 to 58.1). At each subsequent collection point the mean excretion rate was always higher with placebo and the cumulative output over the 6 h after frusemide was significantly lower with paracetamol than with placebo pre-treatment (183.3 ± 100.6 vs 305.9 ± 179.7, P < 0.05; 95% confidence interval of the difference -216 to -32.2).
Plasma renin activity
With placebo pre-treatment, frusemide induced an increase in PRA activity up to 1 h (Table 1) and this was significantly reduced with paracetamol at 60 min (4.3 ± 2.9 vs 2.7 ± 1.9 ng ml-' h-1, P < 0.01; 95% confidence interval 0.4 to 2.7).
Discussion
Paracetamol has been considered to be only a weak inhibitor of prostaglandin biosynthesis. However paracetamol therapy reduced the urinary excretion of prostaglandins and consequently blunted the frusemide-induced increase in PGE2 and 6-keto PGFlc Paracetamol also attenuated the rise in PRA activity following frusemide but had little effect on natriuresis or dicuresis.
At least some of the pharmacological actions of frusemide in man are mediated by the prostaglandins and its administration is associated with an increase in urinary prostaglandin excretion [1, 2] . The acute rise in PRA activity following frusemide is prostaglandin-mediated [14] and this effect is consistently blocked by the non-steroidal anti-inflammatory drugs which inhibit the formation of prostaglandins [3] [4] [5] . A later rise is thought to be related to sodium and water depletion. In the present study paracetamol had most effect on PRA activity 60 min after frusemide administration suggesting that a small anti-natriuretic effect may have occurred which was not picked up by the methods used, possibly due to a Type 11 error. The relationship between prostaglandins and the natriuretic effect of frusemide is not clear [6] . Although non-steroidal anti-inflammatory drugs have been found in some cases to reduce the natriuretic response to frusemide [3] [4] [5] other reports showed no such interaction [7] [8] [9] .
Paracetamol was previously shown to cause a reduction in PGE2 excretion in healthy female volunteers under conditions of controlled sodium intake associated with a reduction in sodium output [11] . Paracetamol reduced sodium and water output [15] and it has an antinatriuretic effect in patients with diabetes insipidus [16] . In contrast, Berg et al. Table 1 The diuresis (ml min-'), natriuresis (,umol min-') and plasma renin activity (ng ml-' h-1) observed following the administration of 20 mg frusemide intravenously to 10 healthy female volunteers pre-treated with either placebo or paracetamol ( Short report 467 [ 17] found reduced sodium and PGE2 output in elderly volunteers but not young subjects and Bippi & Frohlich [18] were unable to demonstrate a reduction in urinary PGE2 excretion following paracetamol in female volunteers. The present results confirm previous reports suggesting that paracetamol shares at least some of the renal properties of the non-steroidal anti-inflammatory drugs.
